Enzyme-triggered nanomedicine: drug release strategies in cancer therapy.
about
Enzyme-responsive nanomaterials for controlled drug deliveryPhotoacoustic Imaging of Cancer Treatment Response: Early Detection of Therapeutic Effect from Thermosensitive LiposomespH-triggered echogenicity and contents release from liposomes.Ultrasound enhanced matrix metalloproteinase-9 triggered release of contents from echogenic liposomes.Steric environment around acetylcholine head groups of bolaamphiphilic nanovesicles influences the release rate of encapsulated compounds.Liposomal nanostructures for photosensitizer delivery.Esterase-activated release of naproxen from supramolecular nanofibres.Rapid detection and destruction of squamous cell carcinoma of the head and neck by nano-quadrapeutics.Physical and chemical strategies for therapeutic delivery by using polymeric nanoparticles.Nanotechnology-based approaches in anticancer researchPhosphatase-triggered fusogenic liposomes for cytoplasmic delivery of cell-impermeable compounds.Acid-labile mPEG-vinyl ether-1,2-dioleylglycerol lipids with tunable pH sensitivity: synthesis and structural effects on hydrolysis rates, DOPE liposome release performance, and pharmacokinetics.Matrix metalloproteinases-2/9-sensitive peptide-conjugated polymer micelles for site-specific release of drugs and enhancing tumor accumulation: preparation and in vitro and in vivo evaluationFunctional lipids and lipoplexes for improved gene delivery.Hyperthermia-induced drug targeting.Functional block copolymer assemblies responsive to tumor and intracellular microenvironments for site-specific drug delivery and enhanced imaging performance.Self-assembled liposomal nanoparticles in photodynamic therapy.Recent advances in biocompatible nanocarriers for delivery of chemotherapeutic cargoes towards cancer therapy.Electrophoretic separation techniques and their hyphenation to mass spectrometry in biological inorganic chemistry.Investigation of enzyme-sensitive lipid nanoparticles for delivery of siRNA to blood-brain barrier and glioma cells.Enzyme-triggered delivery of chlorambucil from conjugates based on the cell-penetrating peptide BP16.Selective non-covalent triggered release from liposomes.Effective nanoparticle-based gene delivery by a protease triggered charge switch.Microfluidic Assembly of Cationic-β-Cyclodextrin:Hyaluronic Acid-Adamantane Host:Guest pDNA Nanoparticles.A core-shell albumin copolymer nanotransporter for high capacity loading and two-step release of doxorubicin with enhanced anti-leukemia activity.Near-infrared light for on-demand drug delivery.Differential toxicological response to positively and negatively charged nanoparticles in the rat brain.Liposome-encapsulated chemotherapy: Current evidence for its use in companion animals.Stimulation-Sensitive Drug Delivery SystemsPhotoresponsive amphiphilic azobenzene–PEG self-assembles to form supramolecular nanostructures for drug delivery applicationsPermeability Variation Study in Collagen-Based Polymeric CapsulesAdvances in redox-responsive drug delivery systems of tumor microenvironment
P2860
Q26992127-3123A7FF-70BC-49CF-83C0-D44E17656209Q28553001-9B8D2F86-A074-498C-BC7E-680B6410F3D0Q30402045-DBE5EA27-1E78-4D1C-8E95-C8DAB5CB7776Q30449753-ED4DF87F-0C01-4638-8ABD-213FD2E0E093Q30568293-104AAE86-CAAA-4DC5-92A3-0F92A096BA6EQ34068206-FB63AB6D-B5DC-4DB2-AF06-FB7CE76D33BEQ34362010-B5BC0ADC-6C90-4ABC-B2C3-2AD784D64869Q35560212-FD55F564-6EB4-41F5-BB15-4D7188A5E4FAQ36105465-43C32CC5-1745-483F-89D5-19E0704A73A4Q36168983-D8A57C1B-FDA6-4E64-B833-072AF096E6D4Q36315665-F7E8C97F-3578-41FD-8299-14CBCBA490CEQ36374025-5CF00847-5EA5-4D2B-9C26-7CAC4A29A9BAQ36857828-6A4336C2-337C-4AA8-89F4-DF8F27A46676Q37166374-384AB579-F1EB-40D5-8AA9-0384B10BD54EQ38071664-9D41653E-D66E-4AA6-8B41-30E54EB177BCQ38095361-14F0E1A8-F37F-410A-A80F-4221386E6360Q38172124-420495EA-7C07-4917-A7C8-93204EEE2F1CQ38204933-1A3BB9F7-FA87-4CF4-9352-BCDB1186C10EQ38661389-15C92E07-0F72-4BC0-92A0-6E5591976726Q38829253-AB861427-A909-410F-AA21-7AEFDC0F930AQ38932275-35490FDC-2AF9-405C-99F4-287040EF2367Q42125287-DFE6C6DE-7D8D-425D-9941-51FF6DBD2747Q42229992-1498A8F7-1D00-424E-B4D6-B76BF530BB9BQ42818425-B110B476-770E-46A9-8BB2-A2093D287D2BQ46216740-AB27FED2-05DC-43D4-AE17-82B077113182Q47399711-9669E64E-7246-41BF-9B11-4C0F3CF92C95Q47928969-E97E013A-A131-47DA-8E23-FF44813034D4Q48192967-A574FDD6-CA08-49AC-8C6E-85AEACD66096Q57341240-82535A85-83F7-4FB9-A27A-B714E802A4D8Q57366667-421E8CA1-AF55-462E-8D43-80BADEB1B948Q57985476-0BD4B01C-1BE4-422D-AE50-152BC3522AB2Q58702312-0BA768E1-34EA-4574-B1B8-1DF47A93BE3F
P2860
Enzyme-triggered nanomedicine: drug release strategies in cancer therapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 October 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Enzyme-triggered nanomedicine: drug release strategies in cancer therapy.
@en
Enzyme-triggered nanomedicine: drug release strategies in cancer therapy.
@nl
type
label
Enzyme-triggered nanomedicine: drug release strategies in cancer therapy.
@en
Enzyme-triggered nanomedicine: drug release strategies in cancer therapy.
@nl
prefLabel
Enzyme-triggered nanomedicine: drug release strategies in cancer therapy.
@en
Enzyme-triggered nanomedicine: drug release strategies in cancer therapy.
@nl
P2860
P1476
Enzyme-triggered nanomedicine: drug release strategies in cancer therapy
@en
P2093
David H Thompson
Thomas Kaasgaard
P2860
P304
P356
10.3109/09687688.2010.515950
P577
2010-10-13T00:00:00Z